IT Pro is supported by its audience. When you purchase through links on our site, we may earn an affiliate commission. Learn more

Pharma transactions during the COVID-19 pandemic

How resilient were they?

Whitepaper front cover
whitepaper

Provided by

Sterling logo

FREE DOWNLOAD

With deal volumes in pharma going against forecasts and rising significantly during the pandemic, this paper takes a close look at how deal flow was maintained during such tough working conditions. Of course, new processes played a big role. But so did the attitudes and resilience of those individuals involved who had to adapt to such unfamiliar conditions.

This paper explores the: 

• Use of technology, from zoom to digital signatures 

• Subsequent increased scrutiny on cyber security and business continuity 

• Impact on contract negotiation, speed of decision making and people 

• Post pandemic world and what it could hold for deals in pharma going forward 

. 

Recommended

CMO job description: What does a chief marketing officer do?
Business strategy

CMO job description: What does a chief marketing officer do?

9 Jun 2022
CFO job description: What does a chief financial officer do?
Business strategy

CFO job description: What does a chief financial officer do?

9 Jun 2022
What does a CISO do?
Careers & training

What does a CISO do?

12 May 2022
Business value on AWS
Whitepaper

Business value on AWS

27 Apr 2022

Most Popular

How to boot Windows 11 in Safe Mode
Microsoft Windows

How to boot Windows 11 in Safe Mode

7 Jun 2022
Delivery firm Yodel disrupted by cyber attack
cyber attacks

Delivery firm Yodel disrupted by cyber attack

21 Jun 2022
Swift exit: How the world cut off Russian banks
finance

Swift exit: How the world cut off Russian banks

24 Jun 2022
What is GPT-4?
artificial intelligence (AI)

What is GPT-4?

17 Jun 2022